Press Releases

Featured Press Releases

BIO Statement Regarding Nomination of Robert F…

BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…

Learn more

BIO Released the Following Statement After…

“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…

Learn more

BIO Statement on Lawsuit Over 340B Rebates

BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…

Learn more

BIO Congratulates Members for Presidential Green Chemistry Challenge Awards

June 12, 2017

Washington, D.C. (June 12, 2017) – The Biotechnology Innovation Organization (BIO) today congratulated member companies Merck & Co., Inc., Amgen Inc., and Dow Chemical Company for receiving 2017 Presidential Green Chemistry Challenge Awards. The…

BIO World Congress Announces 2017 GreenTech Investor Sessions

June 8, 2017

BIO today announced that eleven emerging companies will make formal presentations to investors during GreenTech Investor Sessions at the 2017 BIO World Congress on Industrial Biotechnology.

Convention to Feature Modern Ag Innovation Programming

June 6, 2017

Washington, D.C. (June 6, 2017) – Today, BIO announced programming and speakers for its Modern Ag Innovation Day, which will take place on Tuesday, June 20th at BIO’s 2017 International Convention (June 19-22 in San Diego). Programming will feature…

GM Crops Increase Environmental Sustainability and Farmer Incomes

June 5, 2017

Washington, D.C. (June 5, 2017) – Over the last twenty years, biotech crops have increased agriculture’s environmental sustainability, while providing significant economic benefits, according to a newly released global impacts study.

BIO Statement on Supreme Court Ruling in Impression Products v. Lexmark International

May 30, 2017

Washington, DC (May 30, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to the Supreme Court’s ruling in Impression Products v. Lexmark International.

POET Founder, Chairman and CEO Jeff Broin to Receive 2017 BIO George Washington Carver Award

May 25, 2017

BIO today announced that POET Founder, Chairman and CEO Jeff Broin will receive the 10th annual George Washington Carver Award for Innovation in Industrial Biotechnology. The award will be presented on Monday July 24, 2017, during a morning plenary…

BIO Applauds Creation of FDA Opioid Policy Steering Committee

May 24, 2017

Washington, DC (May 24, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the announced creation of an Opioid Policy Steering Committee at the Food and Drug…

Astellas Expands Advocacy Engagement with Focused Outreach

May 23, 2017

Astellas recognizes the crucial role that patient groups play in enhancing and extending the lives of patients. Sponsoring events such as the BIO Patient and Health Advocacy Summit to be held on November 3-4 is a way the Astellas…

BIO Statement on President’s Proposed 2018 Budget

May 23, 2017

Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to President Trump’s FY 2018 budget proposal.

Biotech Industry Continues Strong Growth in 2016; San Diego Setting Pace for State, Nation

May 17, 2017

Mayor Faulconer, Industry Leaders Reveal Latest Data, Including Major Economic Benefits of June BIO 2017 Convention

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.